11 reports of this reaction
3.5% of all ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE reports
#1 most reported adverse reaction
CHRONIC KIDNEY DISEASE is the #1 most commonly reported adverse reaction for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, manufactured by Walgreens. There are 11 FDA adverse event reports linking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE to CHRONIC KIDNEY DISEASE. This represents approximately 3.5% of all 310 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE who experience chronic kidney disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CHRONIC KIDNEY DISEASE is moderately reported among ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE users, representing a notable but not dominant share of adverse events.
In addition to chronic kidney disease, the following adverse reactions have been reported for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE:
The following drugs have also been linked to chronic kidney disease in FDA adverse event reports:
CHRONIC KIDNEY DISEASE has been reported as an adverse event in 11 FDA reports for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CHRONIC KIDNEY DISEASE accounts for approximately 3.5% of all adverse event reports for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, making it one of the most commonly reported side effect.
If you experience chronic kidney disease while taking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.